Document is current
Any future updates will be listed below
-
Authors
Baudouin, Christophe
Stalmans, Ingeborg
Bourne, Rupert
Larrosa, Jose Manuel
Schmickler, Stefanie
Seleznev, Aleksey
Oddone, Francesco https://orcid.org/0000-0002-2504-0004
,
El-Shabrawi, Yosuf
Garhoefer, Gerhard
Mossboeck, Georg
Stalmans, Ingeborg
Kaljurand, Kuldar
Noor, Kai
Jugaste, Tia
Kaarniranta, Kai
Baudouin, Christophe
Santiago, Pierre Yves
Labetoulle, Marc
Schweitzer, Cedric
Vabres, Bertand
Lorenz, Katrin
Schuart, Claudia
Spitzer, Martin
Hamacher, Thomas
Schmickler, Stefanie
Thelen, Ulrich
Oddone, Franceso
Barabino, Stefano
Manni, Gianluca
Leonardi, Andrea
Rossi, Gemma Caterina Maria
Lanzetta, Paolo
Baumane, Kristine
Lagnovska, Guna
Grundmane, Iveta
Rekas, Marek
Siewierska, Malgorzata
Mrukwa-Kominek, Ewa
Fryczkowski, Piotr
Malyugin, Boris
Lebedev, Oleg Ivanovich
Bratko, Galina
Astakhov, Turiy Sergeevich
Boiko, Ernest Vitalyevich
Abduleva, Elmira
Gavrilova, Natalia Aleksandrovna
Gornostaeva, Ekaterina
Seleznev, Aleksey
Pozdeeva, Nadezhda
Molokov, Kirill
Kim, Chan Yun
Park, Ki Ho
Park, Chan Kee
Belda, Jose I.
Lopez, Fernando Lopez
Larrosa, José Manuel
Feijóo, Julián García
Pazos, Marta
Morena-Montañes, Javier
Calvo, Pedro Pablo Rodriguez
Canut, Maria Isabel
López, Alfonso Antón
Hanspal, Inderraj
Bourne, Rupert
Kirwan, James
Cordeiro, Francesca
-
Funding
Funding for this research was provided by:
Santen Oy
Santen Oy and partially supported by Fondazione Roma.
- License Information
-
More Information
Article History
Received: 22 May 2024
Revised: 6 January 2025
Accepted: 24 January 2025
First Online: 25 February 2025
Competing interests
: Christophe Baudouin is a consultant for Alcon, Bausch & Lomb, Horus Pharma, Oculis, Santen and Théa. Ingeborg Stalmans received grant/research support from Théa and Santen, clinical trial participation from Théa and Santen, honoraria/consulting fees from Alcon, Allergan/AbbVie, Elios, EyeD, Horus, Santen and Théa, and investments (stock options etc.) from Mona. Rupert Bourne received grant/research support from Théa, Santen, GSK and Allergan/AbbVie. Jose Manuel Larrosa received consulting and speaker fees from Allergan/AbbVie, Bausch & Lomb and Johnson & Johnson. Stefanie Schmickler received honoraria/consulting fees from Bayer, Johnson & Johnson, Kowa, Rayner, and Ziemer and clinical trial fees from Santen. Francesco Oddone is a consultant for AbbVie, Santen, Omikron Italia, Sooft and Théa; received speaker fees from Santen and Omikron Italia, Théa and Aerie; and grants from AbbVie, Santen and Omikron Italia. Aleksey Seleznev has no conflicts of interest to disclose.
